Finckenstein Friedrich Graf insider trades

Open-market stock purchases and sales by Finckenstein Friedrich Graf, Chief Medical Officer at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Jul 18, 2019.

Recent trades

DateStockTradeValue
Jun 5, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$16.8K
Jun 5, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Jun 1, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$17.7K
Jun 1, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 9, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 5, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$75.7K
Mar 5, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 2, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 2, 2026IOVA Iovance Biotherapeutics, IncSold (not open market)$27K
Mar 2, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Mar 2, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Dec 2, 2025IOVA Iovance Biotherapeutics, IncSold (not open market)$4.2K
Dec 2, 2025IOVA Iovance Biotherapeutics, IncBought (not open market)—
Dec 1, 2025IOVA Iovance Biotherapeutics, IncSold (not open market)$10K
Dec 1, 2025IOVA Iovance Biotherapeutics, IncBought (not open market)—

Companies traded

  • IOVA Iovance Biotherapeutics, Inc: other filings, last Jun 5, 2026

Get free alerts when Finckenstein Friedrich Graf files a new trade →